Product Description
Matriks Biotek Shikari® Shikari® T-CAP NAB ASSAY-CERTOLIZUMAB - Certolizumab (Cimzia®) (Free neutralizing ADA - qualitative screening) ELISA Kit
Enzyme immunoassay to detect neutralizing antibodies to certolizumab in serum and plasma samples (Target Capture Neutralizing Antibodies Immunoassay-Certolizumab)
This kit has been developed for detecting Free neutralizing antibodies to certolizumab. The kit is composed of 4 different controls. With these controls, the kit provides reliable results. The kit was also checked with various negative serum samples, including RF(+), CRP(+), ANA(+) sera. All these negative sera did not interfere with the test system. Please refer to the validation report.
Specifications:
| Required Volume (µl) | 10 |
| Total Time (min) | 140 |
| Sample | Serum, plasma |
| Sample Number | 96 |
| Detection Limit (ng/mL) | 50 |
| Spike Recovery (%) | - |
| Shelf Life (months) | 6 |
Standard Lead time : 3-4 Weeks (subject to change)
Documentation
Download sample IFU
Download sample MSDS
Please note that the documentation provided is for reference use only. For the most updated version, please contact us.
For Research Use Only
Manufactured by Matriks Biotek Co.
| Questions about this product? Ready to place an order? Email us at orders@iwai-chem.com or give us a call: (650) 486-1541 |
